Table 2.
Main OOP cost inputs for the ECEA, including ranges used in sensitivity analysis
| Yearly cost* | Mean value per income quintile |
||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | Q5 | |
| Hypertension | $2 | $4 | $7 | $12 | $24 |
| (Range) | (1–5) | (2–7) | (3–13) | (6–23) | (12–48) |
| Stroke | $18 | $39 | $100 | $288 | $863 |
| (Range) | (10–42) | (21–82) | (54–215) | (162–649) | (565–2260) |
| IHD | $22 | $52 | $128 | $338 | $992 |
| (Range) | (13–53) | (28–111) | (71–283) | (201–805) | (730–2919) |
| HHF | $15 | $29 | $74 | $212 | $638 |
| (Range) | (8–31) | (15–59) | (37–149) | (108–432) | (332–1333) |
| ESRD | $151 | $221 | $388 | $630 | $1731 |
| (Range) | (75–301) | (111–442) | (194–262) | (315–1261) | (866–3462) |
OOP, out-of-pocket; IHD, ischemic heart disease; HHF, hypertensive heart failure; ESRD, end-stage renal disease. Q1, poorest quintile; Q5, wealthiest quintile. Currency is 2012 USD. For details of the costing methodology, assumptions and data sources, please see Supplementary S3.
*All costs are reported in 2012 USD.